BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $35.65 million. The enterprise value is $108.76 million.

Market Cap	35.65M
Enterprise Value	108.76M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BTAI has 21.87 million shares outstanding. The number of shares has increased by 235.79% in one year.

Current Share Class	21.87M
Shares Outstanding	21.87M
Shares Change (YoY)	+235.79%
Shares Change (QoQ)	+81.00%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	12.11%
Float	21.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.27
Forward PS	33.28
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	144.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.17

Current Ratio	1.17
Quick Ratio	0.96
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-67.31%
Return on Invested Capital (ROIC)	-158.82%
Return on Capital Employed (ROCE)	-721.89%
Revenue Per Employee	$20,324
Profits Per Employee	-$1.84M
Employee Count	37
Asset Turnover	0.02
Inventory Turnover	0.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.54% in the last 52 weeks. The beta is 0.22, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-83.54%
50-Day Moving Average	2.50
200-Day Moving Average	2.43
Relative Strength Index (RSI)	31.00
Average Volume (20 Days)	731,607

Short Selling Information

The latest short interest is 1.40 million, so 6.41% of the outstanding shares have been sold short.

Short Interest	1.40M
Short Previous Month	1.14M
Short % of Shares Out	6.41%
Short % of Float	6.61%
Short Ratio (days to cover)	1.39

Income Statement

In the last 12 months, BTAI had revenue of $752,000 and -$68.21 million in losses. Loss per share was -$9.09.

Revenue	752,000
Gross Profit	-212,000
Operating Income	-50.45M
Pretax Income	-68.21M
Net Income	-68.21M
EBITDA	-50.14M
EBIT	-50.45M
Loss Per Share	-$9.09

Balance Sheet

The company has $36.18 million in cash and $109.29 million in debt, giving a net cash position of -$73.11 million or -$3.34 per share.

Cash & Cash Equivalents	36.18M
Total Debt	109.29M
Net Cash	-73.11M
Net Cash Per Share	-$3.34
Equity (Book Value)	-88.92M
Book Value Per Share	-4.45
Working Capital	6.60M

Cash Flow

Operating Cash Flow	-58.21M
Capital Expenditures	n/a
Free Cash Flow	-58.21M
FCF Per Share	-$2.66

Margins

Gross Margin	-28.19%
Operating Margin	-6,708.24%
Pretax Margin	-9,070.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-235.79%
Shareholder Yield	-235.79%
Earnings Yield	-191.35%
FCF Yield	-163.31%

Analyst Forecast

The average price target for BTAI is $32.80, which is 1,912.27% higher than the current price. The consensus rating is "Buy".

Price Target	$32.80
Price Target Difference	1,912.27%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	137.17%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

BTAI has an Altman Z-Score of -25.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.54
Piotroski F-Score	2